SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo)
DEPO 7.300+1.7%Aug 14 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: biao luo who wrote (636)12/20/1997 7:19:00 PM
From: Cymeed   of 887
 
Another excellent post, Biao. Thanks a lot.

One question asked during the conference call was the Q & L data (Quality of Life Data - I assume it refers to the average dates of survival). Dave Thomas (?), who is the one made the 45 minutes presentation during the ODAC meeting, said he did not mention these data (??? !!!) because he thought that the data were in the application. And the data was likely geting lost in the discusion.

Obviously the company just did a terrible job in presenting their case ! They had no strategy, no analysis, bad preparation, under estimate of the difficulty of the approval process, and the consequence of such a rejection.

I too am worried about the argumentative attitude of management. Hope their follow-up study will use the "intend to study" approach which is more conservative, instead of "evaluable." And it might show a surprise either way.

For now, I am very eager to learn the details of the ODAC meeting. I like to know the bad words as well as the good ones the panelists have said. I'd appreciate very much if someone can post the details or a link as soon as they come out.

BTW, I am holding many shares of Depo bought @ average price of $14.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext